Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Mayo Clinic
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Washington University School of Medicine
M.D. Anderson Cancer Center
UMC Utrecht
Memorial Sloan Kettering Cancer Center
Washington University School of Medicine
University of Florida
Essen Biotech
OHSU Knight Cancer Institute
Baylor College of Medicine
University of Colorado, Denver
Alliance for Clinical Trials in Oncology
Centre Paul Strauss
Roswell Park Cancer Institute
University of Nebraska
University of Michigan Rogel Cancer Center
Kidney Cancer Research Bureau
HealthPartners Institute
University of Kansas Medical Center
NRG Oncology
Medical College of Wisconsin
Fred Hutchinson Cancer Center
Harvard Medical School (HMS and HSDM)
Ohio State University Comprehensive Cancer Center
Mayo Clinic
Centre Hospitalier Universitaire de Besancon
City of Hope Medical Center
University Health Network, Toronto
UNICANCER
Hospices Civils de Lyon
AdventHealth
Dana-Farber Cancer Institute
Virginia Commonwealth University
University of Calgary
Memorial Sloan Kettering Cancer Center
Maastricht Radiation Oncology
Washington University School of Medicine
University of Texas Southwestern Medical Center
Centre Hospitalier de Valence
Mayo Clinic
Washington University School of Medicine
University of Florida
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
The Netherlands Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Institut Bergonié